Product Program year 2025 Source: CMS Open Payments

Spectra Optia

Device Therapeutic apheresis and cell collection

PDI 05020583610002

Open in the dashboard

General payments

$32,851

63 payments

Research payments

$0

0 payments

Through program year 2025, $32,851 in general payments and $0 in research payments were reported against Spectra Optia (Therapeutic apheresis and cell collection).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $32,851 63

Breakdown

Who paid General payments · program year 2025
  1. Terumo BCT, Inc. $32,851 63 payments
Top recipients General payments · program year 2025
  1. Julie Kanter Washko Pediatric Hematology-Oncology · Birmingham, AL $8,505 26% · 5 payments
  2. John Manis Plastic Surgery · Greenbrae, CA $8,000 24% · 3 payments
  3. Erin Goodhue Anatomic Pathology & Clinical Pathology · Columbus, OH $2,400 7% · 2 payments
  4. Tina Ipe Clinical Pathology/Laboratory Medicine · Little Rock, AR $2,400 7% · 2 payments
  5. Asif Alavi Hematology · Detroit, MI $1,495 5% · 2 payments

The top 5 of 50 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $8,966 27% · 5 practitioners
  2. Plastic Surgery $8,000 24% · 1 practitioner
  3. Anatomic Pathology & Clinical Pathology Pathology $4,285 13% · 8 practitioners
  4. Blood Banking & Transfusion Medicine Pathology $2,842 9% · 7 practitioners
  5. Clinical Pathology/Laboratory Medicine Pathology $2,400 7% · 1 practitioner

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Alabama $8,625 26% · 2 recipients
  2. California $8,234 25% · 3 recipients
  3. Ohio $3,775 11% · 2 recipients
  4. Arkansas $2,400 7% · 1 recipient
  5. Michigan $1,729 5% · 2 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

63 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record